Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bausch Health Companies Inc (BHC)

Bausch Health Companies Inc (BHC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,110,351
  • Shares Outstanding, K 358,396
  • Annual Sales, $ 8,027 M
  • Annual Income, $ -560,000 K
  • 60-Month Beta 1.71
  • Price/Sales 1.17
  • Price/Cash Flow 3.15
  • Price/Book N/A
Trade BHC with:

Options Overview Details

View History
  • Implied Volatility 35.87%
  • Historical Volatility 40.50%
  • IV Percentile 16%
  • IV Rank 8.00%
  • IV High 91.99% on 10/09/20
  • IV Low 30.99% on 09/03/21
  • Put/Call Vol Ratio 0.92
  • Today's Volume 5,504
  • Volume Avg (30-Day) 9,443
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 177,320
  • Open Int (30-Day) 177,345

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 1.07
  • Number of Estimates 5
  • High Estimate 1.09
  • Low Estimate 1.06
  • Prior Year 1.31
  • Growth Rate Est. (year over year) -18.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.82 +11.39%
on 09/20/21
29.59 -2.81%
on 09/03/21
+0.80 (+2.86%)
since 08/20/21
3-Month
24.91 +15.46%
on 08/04/21
30.30 -5.08%
on 07/02/21
-0.46 (-1.57%)
since 06/22/21
52-Week
14.86 +93.54%
on 09/30/20
34.80 -17.36%
on 03/09/21
+12.72 (+79.30%)
since 09/22/20

Most Recent Stories

More News
Bausch (BHC) Surges 8%: Is This an Indication of Further Gains?

Bausch (BHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the...

BHC : 28.54 (+1.17%)
Tay-Sachs Disease Drugs Market- Worldwide Opportunities, Driving Forces, COVID-19 Impact Analysis, Future Potential 2030

Research Nester released a report titled "" which delivers detailed overview of the global Tay-Sachs disease drugs market in terms of market segmentation by stage, treatment type, end-user, and by region....

SIOX : 2.32 (+7.41%)
PFE : 44.03 (+0.25%)
BAYN : 0.0100 (unch)
BHC : 28.54 (+1.17%)
ABBV : 106.23 (-0.86%)
AMGN : 214.19 (-0.54%)
NOVN : 8.44 (+0.12%)
PROG : 0.9049 (-1.64%)
Global Sterile Injectable Drugs Market Growth to be Propelled by Increasing R&D Initiatives to Witness Considerable GAGR throughout 2021-2029

Research Nester released a report titled "" which delivers detailed overview of the global sterile injectable drugs market in terms of market segmentation by type, drug class, application, distribution...

SAN : 3.51 (+3.54%)
PFE : 44.03 (+0.25%)
GSK : 39.36 (+0.72%)
BHC : 28.54 (+1.17%)
ABBV : 106.23 (-0.86%)
AMGN : 214.19 (-0.54%)
NOVN : 8.44 (+0.12%)
PROG : 0.9049 (-1.64%)
JNJ : 163.94 (-0.36%)
Tay-Sachs Disease Drugs Market- Sales Outlook, Up-to-date Development Data and Market Trends Forecast 2030

Research Nester released a report titled "" which delivers detailed overview of the global Tay-Sachs disease drugs market in terms of market segmentation by stage, treatment type, end-user, and by region....

SIOX : 2.32 (+7.41%)
PFE : 44.03 (+0.25%)
BAYN : 0.0100 (unch)
BHC : 28.54 (+1.17%)
ABBV : 106.23 (-0.86%)
AMGN : 214.19 (-0.54%)
NOVN : 8.44 (+0.12%)
PROG : 0.9049 (-1.64%)
Global Sterile Injectable Drugs Market to Witness Considerable growth throughout 2021-2029

Research Nester released a report titled "" which delivers detailed overview of the global sterile injectable drugs market in terms of market segmentation by type, drug class, application, distribution...

SAN : 3.51 (+3.54%)
PFE : 44.03 (+0.25%)
GSK : 39.36 (+0.72%)
BHC : 28.54 (+1.17%)
ABBV : 106.23 (-0.86%)
AMGN : 214.19 (-0.54%)
NOVN : 8.44 (+0.12%)
PROG : 0.9049 (-1.64%)
JNJ : 163.94 (-0.36%)
DiGeorge Syndrome Drug Market Propelled by Increased Patient Pool and R&D Initiatives to Witness Substantial GAGR throughout 2021-2029

Research Nester released a report titled "" which delivers detailed overview of the DiGeorge syndrome drug market in terms of market segmentation by therapy type, route of administration, end-user, and...

PFE : 44.03 (+0.25%)
CERC : 2.93 (-1.68%)
BHC : 28.54 (+1.17%)
NTRA : 125.36 (+1.34%)
ABBV : 106.23 (-0.86%)
AMGN : 214.19 (-0.54%)
NOVN : 8.44 (+0.12%)
PROG : 0.9049 (-1.64%)
Turner Syndrome Market: by Industry Type, Growth, Share, Size, Key Manufacturers, Revenue, Trends, Growth, Geographical Outlook and Forecast to 2028

Research Nester published a report titled ": Global Demand Analysis & Opportunity Outlook 2028"which delivers a detailed overview of the turner syndrome drug market in terms of market segmentation by type,...

PFE : 44.03 (+0.25%)
NOVN : 8.44 (+0.12%)
BHC : 28.54 (+1.17%)
JNJ : 163.94 (-0.36%)
LLY : 228.86 (-0.57%)
ABT : 124.34 (-0.63%)
MRK : 71.99 (+0.03%)
SAN : 3.51 (+3.54%)
GSK.LN : 1,429.000 (+0.70%)
Wilson Disease Drugs Market: Trends, Key Players, Overview, Competitive Breakdown and Regional Forecast by 2029

Research Nester has released a report titled "" which delivers detailed overview of the global Wilson disease drugs market in terms of market segmentation by indication, drug type, end-user and by region....

MRK : 71.99 (+0.03%)
BHC : 28.54 (+1.17%)
ALXN : 182.50 (+1.70%)
KDMN : 8.96 (+1.82%)
TEVA : 8.83 (+1.73%)
AptarGroup (ATR) Buys Stake in Voluntis, Boosts Capabilities

AptarGroup (ATR) completes the acquisition of 64.6% stake in Voluntis, which will help expand its digital healthcare offerings and drive innovation in the healthcare space.

ATR : 120.62 (+0.47%)
BDC : 57.63 (+3.45%)
CMCO : 43.17 (-0.14%)
BHC : 28.54 (+1.17%)
Salix Will Share RELISTOR® (Methylnaltrexone Bromide) Data At PAINWeek 2021

/PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the largest specialty pharmaceutical companies...

BHC : 28.54 (+1.17%)
BHC.TO : 36.50 (+1.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Bausch Health Companies Inc. develops and distributes drugs. It develops drugs for unmet medical needs in central nervous system disorders and distributes generic and branded generic drugs primarily in Latin America and Eastern Europe. Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals,...

See More

Key Turning Points

3rd Resistance Point 29.97
2nd Resistance Point 29.23
1st Resistance Point 28.72
Last Price 28.54
1st Support Level 27.47
2nd Support Level 26.74
3rd Support Level 26.23

See More

52-Week High 34.80
Last Price 28.54
Fibonacci 61.8% 27.18
Fibonacci 50% 24.83
Fibonacci 38.2% 22.48
52-Week Low 14.86

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar